Education
About Us
Working with TipRanks
Follow Us
Tolga Tanguler Insider Profile
4 Followers
Tolga Tanguler, EVP & CCO at Alnylam Pharma, holds 34.30K shares in Alnylam Pharma (Ticker: ALNY), holds ― shares in Lexeo Therapeutics, Inc. (Ticker: LXEO). Most recently, Tolga Tanguler Sold ― shares of Alnylam Pharma on Mar 06, 2026 for an estimated value of $745.98K.
Profitable Transactions
7 out of 11 Profitable Transactions
Average Return
-7.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Tolga Tanguler holds in companies
Most Profitable Insider Trade
The most profitable trade made by Tolga Tanguler
Tolga Tanguler's Trading History
Alnylam Pharma
Mar 06, 2026
EVP & CCO
Informative Sell
745.98K
$10.75M
Lexeo Therapeutics, Inc.
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Tolga Tanguler's performance on stock
You May Also Like
Tolga Tanguler insider profile FAQ
What is the percentage of profitable transactions made by Tolga Tanguler?
The percentage of profitable transactions made by Tolga Tanguler is 64%.
What is the average return per transaction made by Tolga Tanguler?
The average return per transaction made by Tolga Tanguler is -7.60%.
What stocks does Tolga Tanguler hold?
Tolga Tanguler holds: ALNY, LXEO stocks.
What was Tolga Tanguler’s latest transaction?
Tolga Tanguler latest transaction was an Informative Sell of $745.98K.
What was Tolga Tanguler's most profitable transaction?
Tolga Tanguler’s most profitable transaction was an Informative Sell of ALNY stock on August 19, 2025. The return on the trade was 31.60%.
What is Tolga Tanguler's role in Alnylam Pharma?
Tolga Tanguler's role in Alnylam Pharma is EVP & CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.